Hyperglycemic crises resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
Line 15: | Line 15: | ||
* Deficiency of [[insulin]] or inadequate treatment | * Deficiency of [[insulin]] or inadequate treatment | ||
* [[Dehydration]] | * [[Dehydration]] | ||
* [[Drug intoxication]] | |||
* [[Insulin pump|Failure of pump therapy]]<ref name="Rosenbloom-2010">{{Cite journal | last1 = Rosenbloom | first1 = AL. | title = The management of diabetic ketoacidosis in children. | journal = Diabetes Ther | volume = 1 | issue = 2 | pages = 103-20 | month = Dec | year = 2010 | doi = 10.1007/s13300-010-0008-2 | PMID = 22127748 }}</ref><ref name="Baird-2009">{{Cite journal | last1 = Baird | first1 = JS. | title = Relapse of diabetic ketoacidosis secondary to insulin pump malfunction diagnosed by capillary blood 3-hydroxybutyrate: a case report. | journal = Cases J | volume = 2 | issue = | pages = 8012 | month = | year = 2009 | doi = 10.4076/1757-1626-2-8012 | PMID = 19918445 }}</ref> | * [[Insulin pump|Failure of pump therapy]]<ref name="Rosenbloom-2010">{{Cite journal | last1 = Rosenbloom | first1 = AL. | title = The management of diabetic ketoacidosis in children. | journal = Diabetes Ther | volume = 1 | issue = 2 | pages = 103-20 | month = Dec | year = 2010 | doi = 10.1007/s13300-010-0008-2 | PMID = 22127748 }}</ref><ref name="Baird-2009">{{Cite journal | last1 = Baird | first1 = JS. | title = Relapse of diabetic ketoacidosis secondary to insulin pump malfunction diagnosed by capillary blood 3-hydroxybutyrate: a case report. | journal = Cases J | volume = 2 | issue = | pages = 8012 | month = | year = 2009 | doi = 10.4076/1757-1626-2-8012 | PMID = 19918445 }}</ref> | ||
* [[Medications]] ([[corticosteroid]], [[pentamidine]],<ref name="Lambertus-1988">{{Cite journal | last1 = Lambertus | first1 = MW. | last2 = Murthy | first2 = AR. | last3 = Nagami | first3 = P. | last4 = Goetz | first4 = MB. | title = Diabetic ketoacidosis following pentamidine therapy in a patient with the acquired immunodeficiency syndrome. | journal = West J Med | volume = 149 | issue = 5 | pages = 602-4 | month = Nov | year = 1988 | doi = | PMID = 3150636 }}</ref> [[clozapine]]) <ref name="Ai-1998">{{Cite journal | last1 = Ai | first1 = D. | last2 = Roper | first2 = TA. | last3 = Riley | first3 = JA. | title = Diabetic ketoacidosis and clozapine. | journal = Postgrad Med J | volume = 74 | issue = 874 | pages = 493-4 | month = Aug | year = 1998 | doi = | PMID = 9926128 }}</ref> | * [[Medications]] ([[corticosteroid]], [[pentamidine]],<ref name="Lambertus-1988">{{Cite journal | last1 = Lambertus | first1 = MW. | last2 = Murthy | first2 = AR. | last3 = Nagami | first3 = P. | last4 = Goetz | first4 = MB. | title = Diabetic ketoacidosis following pentamidine therapy in a patient with the acquired immunodeficiency syndrome. | journal = West J Med | volume = 149 | issue = 5 | pages = 602-4 | month = Nov | year = 1988 | doi = | PMID = 3150636 }}</ref> [[clozapine]]) <ref name="Ai-1998">{{Cite journal | last1 = Ai | first1 = D. | last2 = Roper | first2 = TA. | last3 = Riley | first3 = JA. | title = Diabetic ketoacidosis and clozapine. | journal = Postgrad Med J | volume = 74 | issue = 874 | pages = 493-4 | month = Aug | year = 1998 | doi = | PMID = 9926128 }}</ref> | ||
* [[MI]] | * [[MI]] | ||
* [[Pneumonia]]<ref name="Umpierrez-2003">{{Cite journal | last1 = Umpierrez | first1 = GE. | last2 = Kitabchi | first2 = AE. | title = Diabetic ketoacidosis: risk factors and management strategies. | journal = Treat Endocrinol | volume = 2 | issue = 2 | pages = 95-108 | month = | year = 2003 | doi = | PMID = 15871546 }}</ref> | |||
* [[Pregnancy]]<ref name="Parker-2007">{{Cite journal | last1 = Parker | first1 = JA. | last2 = Conway | first2 = DL. | title = Diabetic ketoacidosis in pregnancy. | journal = Obstet Gynecol Clin North Am | volume = 34 | issue = 3 | pages = 533-43, xii | month = Sep | year = 2007 | doi = 10.1016/j.ogc.2007.08.001 | PMID = 17921013 }}</ref> | * [[Pregnancy]]<ref name="Parker-2007">{{Cite journal | last1 = Parker | first1 = JA. | last2 = Conway | first2 = DL. | title = Diabetic ketoacidosis in pregnancy. | journal = Obstet Gynecol Clin North Am | volume = 34 | issue = 3 | pages = 533-43, xii | month = Sep | year = 2007 | doi = 10.1016/j.ogc.2007.08.001 | PMID = 17921013 }}</ref> | ||
* [[Surgery]]<ref name="MacGillivray-1981">{{Cite journal | last1 = MacGillivray | first1 = MH. | last2 = Bruck | first2 = E. | last3 = Voorhess | first3 = ML. | title = Acute diabetic ketoacidosis in children: role of the stress hormones. | journal = Pediatr Res | volume = 15 | issue = 2 | pages = 99-106 | month = Feb | year = 1981 | doi = 10.1203/00006450-198102000-00002 | PMID = 6789292 }}</ref> | * [[Surgery]]<ref name="MacGillivray-1981">{{Cite journal | last1 = MacGillivray | first1 = MH. | last2 = Bruck | first2 = E. | last3 = Voorhess | first3 = ML. | title = Acute diabetic ketoacidosis in children: role of the stress hormones. | journal = Pediatr Res | volume = 15 | issue = 2 | pages = 99-106 | month = Feb | year = 1981 | doi = 10.1203/00006450-198102000-00002 | PMID = 6789292 }}</ref> | ||
* [[UTI]] | |||
==Management== | ==Management== |
Revision as of 19:33, 4 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vidit Bhargava, M.B.B.S [2]
Definition
Diabetic ketoacidosis is a life threatening complication of untreated or inadequately treated diabetes mellitus and is characterized by hyperglycemia, acidosis and elevated ketone levels.
Causes
Life Threatening Causes
Diabetic ketoacidosis is a life-threatening condition and must be treated as such irrespective of the causes. Life-threatening conditions may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Alcohol
- Deficiency of insulin or inadequate treatment
- Dehydration
- Drug intoxication
- Failure of pump therapy[1][2]
- Medications (corticosteroid, pentamidine,[3] clozapine) [4]
- MI
- Pneumonia[5]
- Pregnancy[6]
- Surgery[7]
- UTI
Management
Diabetic ketoacidosis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
H/O suggestive of DKA: Abdominal pain, altered mentation, drowsiness, fever, Kussmaul breathing, malaise, vomiting Precipitating factors: Infections, insulin deficiency, MI, new onset DM type 1, pregnancy, stress | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check labs ABG, CBC, Chem 7, CXR, EKG, serum glucose, serum & urinary ketones, urine routine | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic criteria Anion gap > 10 Blood glucose > 250 mg/dL pH < 7.3 Serum bicarbonate < 18 mEq/L Serum ketones (+) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IV fluid therapy | Insulin | Need for K+ replacement? | Need for bicarbonate replacement? | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check hydration status | IV | SC for uncomplicated DKA | <3.3 mEq/dL | 3.3-5.3 mEq/dL | >5.3 mEq/dL | pH < 6.9 | pH > 7.0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild dehydration | Severe dehydration | Cardiogenic shock | Regular insulin (0.1 U/kg) bolus | Rapid action insulin 0.3 U/kg then 0.2 U/kg after 1 hr | Hold insulin, supplement K+ (20-30 mEq/hr) till K+ > 3.3 mEq/L | Administer 20-30 mEq/L K+ | Don't supplement, check 2 hourly | Dilute NaHCo3 (100 mmol) in 400 ml H2O with 20 mEq KCl infused over 2 hrs | No bicarbonate needed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluate for corrected Na+ levels | Start 0.9% NaCl (1L/hr) initially | Pressors/ Monitor hemodynamics | Continuous infusion (0.1 U/kg/hr) | SC insulin 0.2 U/kg every 2 hrs | Recheck | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
High Na+ levels | Normal Na+ levels | Low Na+ levels | Double insulin infusion if blood sugar doesn't fall by 50-70 mg/dL in first hr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Switch to 0.45% NaCl (250-500mL/hr) | Continue to 0.9% NaCl (250-500mL/hr) | At serum glucose = 200 mg/dL reduce IV insulin to 0.02-0.05 U/kg/hr or SC insulin (0.1 U/kg) every 2 hrs Target blood sugar to 150-200 mg/dL till DKA resolves | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check blood glucose levels | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
At serum glucose levels ~ 200 mg/dL Switch to 5% dextrose with 0.45% NaCl (150-250 ml/hr) | Check labs every 2-4 hrs Transition to SC insulin (0.8 U/kg/day) when pt tolerates oral feeding Stop IV insulin gradually. Monitor for complications: Hypogylcemia, hypokalemia, cerebral edema, respiratory distress, sepsis, acute gastric dilation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adapted from the recommendations given by American Diabetes Association (ASA) and other sources.[8]
Do's
- Check labs initially and every 2-4 hours.
- Immediately check urine for ketones with dipstick and send urine to the lab for analysis.
- Initiate IV insulin as soon as the patient arrives and satisfies the diagnostic criteria of DKA.
- Assess the trigger that precipitated DKA and treat the cause.
- Admit the patient to the floor; however, if the pH < 7.0 or the patient is unconscious then admit to ICU.
- Assess the hydration status and treat it aggressively as needed.
- Switch to dextrose with normal saline once the blood sugar falls to 200 mg/dL.
- Monitor for complications of DKA itself or of the therapy.
Don'ts
- Do not stop IV insulin until DKA has resolved.
- Do not stop IV insulin, even if SC insulin is administered because it needs time to kick in.
- Do not give insulin if K+ levels are below 3.5 mEq/l because it may further exacerbate the hypokalemia.
- Do not use 0.9% NaCl if corrected Na+ levels > 145 mEq/l, use 0.45% instead.
- Do not supplement phosphate excessively, clinical trials have not shown any benefits. Give only if there is an actual deficiency.
References
- ↑ Rosenbloom, AL. (2010). "The management of diabetic ketoacidosis in children". Diabetes Ther. 1 (2): 103–20. doi:10.1007/s13300-010-0008-2. PMID 22127748. Unknown parameter
|month=
ignored (help) - ↑ Baird, JS. (2009). "Relapse of diabetic ketoacidosis secondary to insulin pump malfunction diagnosed by capillary blood 3-hydroxybutyrate: a case report". Cases J. 2: 8012. doi:10.4076/1757-1626-2-8012. PMID 19918445.
- ↑ Lambertus, MW.; Murthy, AR.; Nagami, P.; Goetz, MB. (1988). "Diabetic ketoacidosis following pentamidine therapy in a patient with the acquired immunodeficiency syndrome". West J Med. 149 (5): 602–4. PMID 3150636. Unknown parameter
|month=
ignored (help) - ↑ Ai, D.; Roper, TA.; Riley, JA. (1998). "Diabetic ketoacidosis and clozapine". Postgrad Med J. 74 (874): 493–4. PMID 9926128. Unknown parameter
|month=
ignored (help) - ↑ Umpierrez, GE.; Kitabchi, AE. (2003). "Diabetic ketoacidosis: risk factors and management strategies". Treat Endocrinol. 2 (2): 95–108. PMID 15871546.
- ↑ Parker, JA.; Conway, DL. (2007). "Diabetic ketoacidosis in pregnancy". Obstet Gynecol Clin North Am. 34 (3): 533–43, xii. doi:10.1016/j.ogc.2007.08.001. PMID 17921013. Unknown parameter
|month=
ignored (help) - ↑ MacGillivray, MH.; Bruck, E.; Voorhess, ML. (1981). "Acute diabetic ketoacidosis in children: role of the stress hormones". Pediatr Res. 15 (2): 99–106. doi:10.1203/00006450-198102000-00002. PMID 6789292. Unknown parameter
|month=
ignored (help) - ↑ Nyenwe, EA.; Kitabchi, AE. (2011). "Evidence-based management of hyperglycemic emergencies in diabetes mellitus". Diabetes Res Clin Pract. 94 (3): 340–51. doi:10.1016/j.diabres.2011.09.012. PMID 21978840. Unknown parameter
|month=
ignored (help)